Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 502294703

Biomatik Corporation Human Urokinase-Type Plasminogen Activator Receptor, Plaur/Upar Elisa Kit

Supplier:  Biomatik Corporation EKC40126

Encompass_Preferred

Human Urokinase-Type Plasminogen Activator Receptor, Plaur/Upar Elisa Kit for detecting Urokinase-Type Plasminogen Activator Receptor, Plaur/Upar in serum, plasma, tissue homogenates. Species Reactivity: Human (Homo sapiens). Detection Range: 0.625-40ng/ml. Sensitivity: 0.156ng/ml. Format: 96-Well Plate. Assay Type: Sandwich. Assay Time: 1-5h. Accession Number: Q03405; PLAUR. Target Synonyms: CD 87; CD87; CD87 antigen; MO 3; MO3; Monocyte activation antigen Mo3; Plasminogen activator receptor urokinase; Plasminogen activator urokinase receptor; PLAUR; U PAR; u plasminogen activator receptor; U-PAR; u-plasminogen activator receptor form 2; UPA receptor; uPAR; UPAR_HUMAN; Urinary plasminogen activator receptor; URKR; Urokinase plasminogen activator receptor; Urokinase plasminogen activator surface receptor; urokinase-type plasminogen activator (uPA) receptor. Restrictions: For Research Use Only. Not for use in diagnostic procedures.

Catalog No. 50-229-4703


May include imposed supplier surcharges.
Only null left
Add to Cart
This item is not returnable. View return policy

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.